Reviva Pharmaceuticals Holdings (RVPH) Return on Equity [ROE] (2019 - 2026)
Reviva Pharmaceuticals Holdings' Return on Equity [ROE] was -79.77% in Q2 2026, up 47.70 percentage points from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Reviva Pharmaceuticals Holdings came in at -419.97%, up 496.20 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -347.67 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -916.17% in FY2024 (-359.79 pp) and -556.38% in FY2023.
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q1 2022.
- Per Business Quant data, RVPH's Return on Equity [ROE] in the three quarters before Q2 2026 was -127.48% (Q1 2026), -301.04% (Q4 2025) and -1112.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.66% |
| 10 | Reviva Pharmaceuticals Holdings | 4.46 Mn | -82.75 Mn | - | -79.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -79.97% |
| Jun 30, 2026 | -79.77% |
| Mar 31, 2026 | -127.48% |
| Dec 31, 2025 | -301.04% |
| Sep 30, 2025 | -1,112.64% |
| Mar 31, 2024 | -1,822.26% |
| Mar 31, 2023 | -554.52% |
| Dec 31, 2022 | -217.81% |
| Sep 30, 2022 | -118.43% |
| Jun 30, 2022 | -99.78% |
| Mar 31, 2022 | -59.69% |
| Dec 31, 2021 | -27.96% |
| Sep 30, 2021 | -15.53% |
| Jun 30, 2021 | -17.53% |
| Mar 31, 2021 | -41.39% |
| Nov 30, 2020 | -17.25% |
| Aug 31, 2020 | -5.13% |
| May 31, 2020 | 11.74% |
| Nov 30, 2019 | 20.34% |
| Aug 31, 2019 | 17.62% |
API Access
Reviva Pharmaceuticals Holdings Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();